Australia: Patients to get easier access to medical products from IndiMed

Aurora Cannabis has removed the concession card requirement for patients to access medical cannabis products under the Company's IndiMed brand in conjunction with MedReleaf Australia. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products.

"This change to open up patient access to MedReleaf's IndiMed products reflects our dedication to supporting prescribers by creating more seamless and simplified prescribing options," said Andre Jerome, Executive Vice President, Global Business Development at Aurora.